相关实验视频

Updated: Sep 19, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

实施机器学习模型和直接向患者推广计划,用于针对家族性高胆固醇血症的查

Kerrilynn C Hennessey¹, Shoshana H Bardach², Terry Sturke³

¹Heart and Vascular Center, Section of Cardiovascular Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States (Drs Hennessey, Prince, Shi, and McGowan).

Journal of clinical lipidology

|June 7, 2025

概括

一个机器学习模型确定了患家族性高胆固醇血症 (FH) 风险的个体. 这种方法导致15%的标记患者接受了新的FH诊断,显著提高了检测率.

科学领域:

心脏病学心脏病学
遗传学遗传学是一个
医疗信息学医疗信息学

背景情况:

家族性高胆固醇血症 (FH) 是一种遗传性疾病,其特征是高的LDL胆固醇水平,显著增加心血管疾病的风险.
特别是FH的诊断不足,导致治疗延迟,患者的治疗结果较差.

研究的目的:

评估机器学习模型 (MLM) 结合专家图表审查和诊断FH的临床咨询的有效性.
评估旗,识别,网络和交付FH (FIND-FH) 程序的诊断产量和效率.

主要方法:

该FIND-FH计划应用于超过147,000名患者记录,以确定患有FH风险的个人.
专家脂质学家和心脏病学家进行了图表审查,以根据临床标准确认FH,排除了先前诊断或可能性低的患者.
针对符合条件的个人,采用了直接接触患者的外展策略.

主要成果:

在MLM标记388名患者的风险为FH.
在专家审查和排除标准之后,58名患者 (15%) 接受了可能/可能/确定的FH的新诊断.
诊断收益率为15%,与0.4%的一般人口查率相比,这是一个显著的改善.

结论:

在FIND-FH计划中,利用MLM和专家审查,成功提高了FH的诊断率.
尽管它取得了成功,但这个过程是劳动密集型的,突出了提高MLM准确性和简化审查/推广可扩展性的需要.

关键词:

人工智能的人工智能是人工智能.家庭性高胆固醇血症是什么?实施科学实施科学机器学习机器学习推广活动推广活动推广活动预防预防预防查检查查检查查检查

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

相关概念视频

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...